Want to join the conversation?
During 3Q15, $PYPL's transaction revenue was up 18% YoverY while other value added services (OVAS) revenue grew 26% YoverY. Transaction revenue benefited from rising engagement of customers. OVAS benefited from growing penetration of $PYPL Credit and amended agreement with Synchrony Financial.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.